Aerami Therapeutics – Developing Treatment for Serious Cardiopulmonary Conditions
Lisa Yañez, CEO of Aerami Therapeutics, a clinical-stage biopharmaceutical company dedicated to breathing life into the treatment of serious cardiopulm...
5345 articles
Lisa Yañez, CEO of Aerami Therapeutics, a clinical-stage biopharmaceutical company dedicated to breathing life into the treatment of serious cardiopulm...
Rakesh Suri, President and Chief Medical Officer at Fountain Life, a preventative health and longevity company discusses Fountain Life's unique data-dri...
Medical Advisor, Drug Monitoring and Toxicology at Quest Diagnostics discusses a report that he co-authored that found that one in two patients (49%) sh...
Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda discusses the dengue program and the European Commission (EC) approval of t...
Holly Johnson, Director of Medical Information at Myriad Mental Health discusses the GeneSight test that analyzes genes to see how a person may respond ...
Graft-versus-host disease, also known as GVHD, is a life-threatening condition that can occur after an allogeneic stem cell transplant, or the transfer ...
Antonio Anzueto, Professor of Medicine and Section Chief of Pulmonary at South Texas Veterans Healthcare System, an affiliated Institution with the Univ...
Sangamo Therapeutics is working to translate groundbreaking science into genomic cures. Learn more on Health Professional Radio.
Robert Risinger, Chief Medical Officer, Neuroscience at BioXcel Therapeutics, a biopharmaceutical company that uses artificial intelligence (AI) to iden...
Jamie McCoy, General Manager of Theranostics and Radiotherapeutics at GE HealthCare discusses theranostics and how it is changing the treatment of prost...